William Pickering
Stock Analyst at Bernstein
(2.47)
# 2,339
Out of 4,670 analysts
20
Total ratings
53.85%
Success rate
1.9%
Average return
Main Sectors:
Top Industries:
Stocks Rated by William Pickering
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BHVN Biohaven | Maintains: Outperform | $55 → $66 | $45.59 | +44.77% | 2 | Sep 24, 2024 | |
| BMRN BioMarin Pharmaceutical | Maintains: Outperform | $116 → $90 | $64.26 | +40.06% | 4 | Sep 17, 2024 | |
| IONS Ionis Pharmaceuticals | Upgrades: Market Perform | n/a | $34.01 | - | 2 | Jun 14, 2024 | |
| REGN Regeneron Pharmaceuticals | Initiates: Outperform | $1,125 | $738.00 | +52.44% | 1 | Mar 12, 2024 | |
| VRTX Vertex Pharmaceuticals | Downgrades: Market Perform | n/a | $450.97 | - | 5 | Feb 2, 2024 | |
| ALNY Alnylam Pharmaceuticals | Initiates: Outperform | $243 | $244.89 | -0.77% | 1 | Mar 21, 2023 | |
| NTLA Intellia Therapeutics | Initiates: Outperform | $54 | $14.30 | +277.62% | 1 | Mar 21, 2023 | |
| BEAM Beam Therapeutics | Initiates: Market Perform | $37 | $25.05 | +47.70% | 1 | Mar 21, 2023 | |
| ALLO Allogene Therapeutics | Initiates: Market Perform | $6 | $2.21 | +171.49% | 1 | Mar 21, 2023 | |
| CRSP CRISPR Therapeutics AG | Initiates: Market Perform | $44 | $47.88 | -8.10% | 1 | Mar 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $27 | $18.54 | +45.63% | 1 | Mar 21, 2023 |
Biohaven
Sep 24, 2024
Maintains: Outperform
Price Target: $55 → $66
Current: $45.59
Upside: +44.77%
BioMarin Pharmaceutical
Sep 17, 2024
Maintains: Outperform
Price Target: $116 → $90
Current: $64.26
Upside: +40.06%
Ionis Pharmaceuticals
Jun 14, 2024
Upgrades: Market Perform
Price Target: n/a
Current: $34.01
Upside: -
Regeneron Pharmaceuticals
Mar 12, 2024
Initiates: Outperform
Price Target: $1,125
Current: $738.00
Upside: +52.44%
Vertex Pharmaceuticals
Feb 2, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $450.97
Upside: -
Alnylam Pharmaceuticals
Mar 21, 2023
Initiates: Outperform
Price Target: $243
Current: $244.89
Upside: -0.77%
Intellia Therapeutics
Mar 21, 2023
Initiates: Outperform
Price Target: $54
Current: $14.30
Upside: +277.62%
Beam Therapeutics
Mar 21, 2023
Initiates: Market Perform
Price Target: $37
Current: $25.05
Upside: +47.70%
Allogene Therapeutics
Mar 21, 2023
Initiates: Market Perform
Price Target: $6
Current: $2.21
Upside: +171.49%
CRISPR Therapeutics AG
Mar 21, 2023
Initiates: Market Perform
Price Target: $44
Current: $47.88
Upside: -8.10%
Mar 21, 2023
Initiates: Market Perform
Price Target: $27
Current: $18.54
Upside: +45.63%